<?xml version="1.0" encoding="UTF-8"?>
<ref id="B30-vaccines-08-00115">
 <label>30.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Liu</surname>
    <given-names>S.A.</given-names>
   </name>
   <name>
    <surname>Stanfield</surname>
    <given-names>B.A.</given-names>
   </name>
   <name>
    <surname>Chouljenko</surname>
    <given-names>V.N.</given-names>
   </name>
   <name>
    <surname>Naidu</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Langohr</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Del Piero</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Ferracone</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Roy</surname>
    <given-names>A.A.</given-names>
   </name>
   <name>
    <surname>Kousoulas</surname>
    <given-names>K.G.</given-names>
   </name>
  </person-group>
  <article-title>Intramuscular immunization of mice with the live-attenuated herpes simplex virus 1 vaccine strain VC2 expressing equine herpesvirus 1 (EHV-1) glycoprotein D generates anti-EHV-1 immune responses in mice</article-title>
  <source>J. Virol.</source>
  <year>2017</year>
  <volume>91</volume>
  <fpage>e02445-02416</fpage>
  <pub-id pub-id-type="doi">10.1128/JVI.02445-16</pub-id>
  <pub-id pub-id-type="pmid">28404844</pub-id>
 </element-citation>
</ref>
